|本期目录/Table of Contents|

[1]赵蒙蒙,杨俊俊,杨 捷,等.NIPV治疗重症肺炎患者凝血功能及预后的影响因素分析[J].中华肺部疾病杂志,2022,(03):311-315.[doi:10.3877/cma.j.issn.1674-6902.2022.03.005]
　Zhao Mengmeng,Yang Junjun,Yang Jie,et al.Analysis of influencing factors of coagulation function and prognosis of severe pneumonia patients undergoing non-invasive positive pressure ventilation[J].,2022,(03):311-315.[doi:10.3877/cma.j.issn.1674-6902.2022.03.005]
点击复制

NIPV治疗重症肺炎患者凝血功能及预后的影响因素分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年03期
页码:
311-315
栏目:
论著
出版日期:
2022-06-20

文章信息/Info

Title:
Analysis of influencing factors of coagulation function and prognosis of severe pneumonia patients undergoing non-invasive positive pressure ventilation
作者:
赵蒙蒙; 杨俊俊; 杨 捷; 曹柳兆; 桑琳莉
225001 江苏,扬州大学临床医学院 江苏省苏北人民医院呼吸与危重症医学科
Author(s):
Zhao Mengmeng;  Yang Junjun;  Yang Jie;  Cao Liuzhao;  Sang Linli.
Respiratory Medicine Department, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China
关键词:
重症肺炎;  凝血功能;  无创正压通气治疗;  预后;  危险因素
Keywords:
Severe pneumonia;  Coagulation function;  Noninvasive positive pressure ventilation;  Prognosis;  Risk factors
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.03.005
摘要:
目的 分析行无创正压通气(noninvasive positive pressure ventilation, NIPV)治疗的重症肺炎(severe pneumonia, SP)患者凝血功能与预后的关系及影响因素。方法 选择2017年1月至2021年12月因SP入住江苏省苏北人民医院重症监护病房并接受NIPV治疗的患者51例。根据患者凝血功能异常程度分为观察组24例,对照组27例,比较两组凝血功能及预后相关指标; 分析影响预后的危险因素。结果 观察组APTT、PT、INR、D-二聚体明显高于对照组; 观察组患者气管插管比例明显高于对照组,且NIPV持续时间及ICU住院时间均明显长于对照组(P<0.05)。单因素分析结果提示,预后不良患者入院时APACHEⅡ评分、入院后48 h PT、APTT、INR、乳酸水平明显升高; 患者入院时呼吸频率、心率、pH、PaCO2>60 mmHg比例以及NIPV开始时pH、PaO2、FiO2、PaO2/FiO2与患者的不良预后关系密切(P<0.05)。结论 SP患者存在明显的凝血功能异常,且与预后密切相关; 多种因素可影响行NIPV治疗的重症肺炎患者预后。重视并动态评估患者凝血功能可改善治疗预后。
Abstract:
Objective To analyze the relationship between coagulation function and prognosis of severe pneumonia patients treated with noninvasive positive pressure ventilation(NIPV)and its influencing factors. Methods A total of 51 patients with severe pneumonia admitted to the intensive care unit of North Jiangsu People's Hospital from January 2017 to December 2021 and all patients were treated with NIPV. The patients were divided into observation group and control group according to the degree of abnormal coagulation function, and the indexes related to coagulation function and prognosis were detected and compared between these two groups. The respiratory rate, blood pressure, partial oxygen pressure, oxygenation index, lactic acid level and other related indicators of patients before and after non-invasive positive pressure ventilation were compared based on the prognosis of patients, and then the prognostic risk indicators were analyzed. Result 24 of the 51 patients(47.06%)with severe pneumonia had obvious coagulation dysfunction at admission. APTT, PT, INR and D-dimer in the observation group were significantly higher than those in the control group. Compared with the control group, the proportion of tracheal intubation in the observation group was significantly higher than that in the control group, and the duration of NIPV and ICU stay were significantly longer than that in the control group(P<0.05). Univariate analysis indicated that APACHE-Ⅱ scores at admission and PT, APTT, INR and lactic acid levels at 48 hours after admission were significantly increased in the poor prognosis group. In addition, respiratory rate, heart rate, blood pH at admission, proportion of PaCO2>60 mmHg, blood pH, PaO2, FiO2, PaO2/FiO2 at the beginning of NIPV treatment were also closely related to poor prognosis, and the differences were statistically significant. Conclusion There are obvious abnormal coagulation dysfunction in patients with severe pneumonia, which is closely related to prognosis. Multiple factors can influence the outcome of patients with severe pneumonia treated with NIPV. In order to improve the prognosis of patients with severe pneumonia, it is necessary to pay attention to and dynamically evaluate the coagulation function of patients when NIPV treatment is performed.

参考文献/References:

1 Hraiech S, Alingrin J, Dizier S, et al. Time to intubation is associated with outcome in patients with community-acquired pneumonia[J]. PLoS One, 2013, 8(9): e74937.
2 Mizgerd JP. Pathogenesis of severe pneumonia: advances and knowledge gaps[J]. Curr Opin Pulm Med, 2017, 23(3): 193-197.
3 石泽亚, 秦月兰, 祝益民, 等. 纤维支气管镜肺泡灌洗联合振动排痰治疗重症肺炎机械通气患者的效果观察: 一项286例患者前瞻性随机对照研究[J]. 中华危重病急救医学,2017, 29(1): 66-70.
4 Pisani L, Nava S. Noninvasive ventilation in acute hypercapnic respiratory failure[J]. Semin Respir Crit Care Med, 2014, 35(4): 501-506.
5 刘 霜, 朱华栋, 于学忠, 等. 经鼻高流量氧疗和无创正压通气对于肺源性中重度急性呼吸窘迫综合征患者初始治疗的效果评价[J]. 临床急诊杂志, 2020, 21(3): 181-187.
6 傅中明, 顾 霄. 老年重症肺炎患者细胞炎症因子、凝血功能和肺功能变化及危险因素[J]. 中国老年学杂志, 2018, 38(19): 4663-4666.
7 Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin [J]. Int J Mol Sci, 2019, 20(8): DOI: 10.3390/ijms20082004.
8 Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
9 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志, 2016, 39(4): 253-279.
10 滕晓蕾, 谢 云, 谢 晖, 等. ICU收治重症肺炎的预后风险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(3): 299-303.
11 Cutuli SL, Grieco DL, Menga LS, et al. Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia[J]. Curr Opin Infect Dis, 2021, 34(2): 142-150.
12 Saguil A, Fargo MV. Acute respiratory distress syndrome: Diagnosis and Management[J]. Am Fam Physician, 2020, 101(12): 730-738.
13 Zaragoza R, Vidal-Cortés P, Aguilar G, et al. Update of the treatment of nosocomial pneumonia in the ICU[J]. Crit Care, 2020, 24(1): 383.
14 田 雨, 李 杨. 合理行液体监测管理在保护重症肺炎患者中的应用价值[J]. 临床肺科杂志, 2015, 20(5): 886-888.
15 孙忠民, 陈天君, 肖 峰, 等. NIPPV在重症肺炎集束化治疗中的应用[J]. 中国现代医学杂志, 2012, 22(1): 89-91.
16 Skoczyński S, Minarowski , Tobiczyk E, et al. Noninvasive ventilation-facilitated bronchofiberoscopy in patients with respiratory failure[J]. Adv Exp Med Biol, 2019, 1160: 53-64.
17 Gadre SK, Duggal A, Mireles-Cabodevila E, et al. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease(COPD)[J]. Medicine(Baltimore), 2018, 97(17): e0487.
18 周 瑜, 代艳梅, 王一平, 等. 老年重症肺炎患者细胞炎性因子、凝血功能情况及预后的影响因素分析[J]. 临床肺科杂志, 2020, 25(1): 70-73.
19 Innocenti F, Gori AM, Giusti B, et al. Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department[J]. Intern Emerg Med, 2019,14(3):459-466.
20 吴文锋, 常兴芳, 许 倩, 等. 老年社区获得性肺炎并发呼吸衰竭患者血小板及凝血功能变化及意义[J].中国病案,2021,22(2):108-112.
21 Qi X, Dong Y, Lin X, et al. Value of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and red blood cell distribution width in evaluating the prognosis of children with severe pneumonia[J]. Evid Based Complement Alternat Med, 2021, 2021: 1818469.
22 俞建峰, 谈铁武, 周 仪, 等. 早期血小板变化在预测老年重症肺炎患者预后中的价值[J]. 中华老年医学杂志, 2018, 37(11): 1238-1242.
23 李泽伦, 陈伟杰, 崔志新. 行无创通气治疗的重症肺炎患者凝血功能和预后的关系[J]. 临床内科杂志, 2017, 34(10): 703-704.
24 朱宝华, 江 洁, 孙 峰, 等. 早期乳酸清除率及APACHEⅡ评分对老年重症肺炎患者预后判断的研究[J]. 东南大学学报(医学版), 2015, 34(1): 76-79.
25 Howatt M, Klompas M, Kalil AC, et al. Carbapenem antibiotics for the empiric treatment of nosocomial pneumonia: A systematic review and Meta-analysis[J]. Chest, 2021, 159(3): 1041-1054.
26 张嫩英, 孔风娟, 余瑞云, 等. 老年重症肺炎患者炎症因子、D-dimer和血浆纤维结合蛋白动态监测的临床预后价值[J]. 中国老年学杂志, 2021, 41(9): 1836-1839.
27 郭 健, 汤 瑾, 朱 亮, 等. 重症肺炎患者中医证型与氧合指数、乳酸、D-二聚体的关系研究[J]. 实用临床医药杂志, 2021, 25(1): 81-84.
28 Zhou H, Lan T, Guo S. Stratified and prognostic value of admission lactate and severity scores in patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study[J]. Medicine(Baltimore), 2019, 98(41): e17479.
29 史文超, 金寿德. 动脉血气分析在重症肺炎患者预后评估中的临床应用[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(1): 79-80.
30 Kolditz M, Braeken D, Ewig S, et al. Severity assessment and the immediate and long-term prognosis in community-acquired pneumonia[J]. Semin Respir Crit Care Med, 2016, 37(6): 886-896.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金青年科学基金项目(81800049)
通信作者: 桑琳莉, Email: sanglinli@126.com
更新日期/Last Update: 2022-06-20